Phase I Trial of a Novel Anti-GD2 Monoclonal Antibody, Hu14.18K322A, Designed to Decrease Toxicity in Children With Refractory or Recurrent Neuroblastoma
NAVID, Fariba, SONDEL, Paul M, GOLDBERG, Jacob, HANK, Jacquelyn A, BILLUPS, Catherine A, JIANRONG WU, FURMAN, Wayne L, MCGREGOR, Lisa M, OTTO, Mario, GILLIES, Stephen D, HANDGRETINGER, Rupert, SANTANA, Victor M, BARFIELD, Raymond, SHULKIN, Barry L, KAUFMAN, Robert A, ALLAY, Jim A, GAN, Jacek, HUTSON, Paul, SONGWON SEO, KYUNGMANN KIM
Published in Journal of clinical oncology (10.05.2014)
Published in Journal of clinical oncology (10.05.2014)
Get full text
Journal Article